abstract |
The present invention relates to antigen binding proteins and fragments thereof that specifically bind to oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit binding of OSM to the gp130 receptor but which do not interact directly with the site II moiety . The invention also relates to a method for humanizing an antibody. Pharmaceutical compositions, screening and medical treatment methods are further disclosed. |